QuidelOrtho annual stock-based compensation
2020
2021
2022
2023
2024
2025
QuidelOrtho Stock-Based Compensation Growth & History (QDEL)
QuidelOrtho's stock-based compensation was $45.9M for fiscal 2025.
View full QuidelOrtho company overviewQuidelOrtho annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-28 | $45.9M | $3.8M | +9.03% |
| 2024 | 2024-12-29 | $42.1M | −$9.5M | −18.41% |
| 2023 | 2023-12-31 | $51.6M | $3.2M | +6.61% |
| 2022 | 2023-01-01 | $48.4M | $23.0M | +90.55% |
| 2021 | 2022-01-02 | $25.4M | $4.4M | +20.95% |
| 2020 | 2021-01-03 | $21.0M | — | — |
QuidelOrtho quarterly stock-based compensation
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-28 | $12.0M | −$800,000 | −6.25% |
| Q1 2026 | 2026-03-29 | $10.7M | −$900,000 | −7.76% |
| Q4 2025 | 2025-12-28 | $10.8M | $1.2M | +12.50% |
| Q3 2025 | 2025-09-28 | $10.7M | −$1.6M | −13.01% |
| Q2 2025 | 2025-06-29 | $12.8M | $1.6M | +14.29% |
| Q1 2025 | 2025-03-30 | $11.6M | $2.6M | +28.89% |
| Q4 2024 | 2024-12-29 | $9.6M | −$2.7M | −21.95% |
| Q3 2024 | 2024-09-29 | $12.3M | −$1.8M | −12.77% |
| Q2 2024 | 2024-06-30 | $11.2M | −$3.0M | −21.13% |
| Q1 2024 | 2024-03-31 | $9.0M | −$2.0M | −18.18% |
| Q4 2023 | 2023-12-31 | $12.3M | $500,000 | +4.24% |
| Q3 2023 | 2023-10-01 | $14.1M | $800,000 | +6.02% |
| Q2 2023 | 2023-07-02 | $14.2M | −$1.7M | −10.69% |
| Q1 2023 | 2023-04-02 | $11.0M | $3.6M | +48.65% |
| Q4 2022 | 2023-01-01 | $11.8M | — | — |
| Q3 2022 | 2022-10-02 | $13.3M | $6.3M | +90.00% |
| Q2 2022 | 2022-07-03 | $15.9M | $10.1M | +174.14% |
| Q1 2022 | 2022-04-03 | $7.4M | — | — |
| Q3 2021 | 2021-10-03 | $7.0M | — | — |
| Q2 2021 | 2021-07-04 | $5.8M | — | — |
QuidelOrtho stock-based compensation trends
Over the last five fiscal years, QuidelOrtho's stock-based compensation increased from $21.0M to $45.9M, a change of $24.9M. The latest reported quarter, Q2 2026, shows $12.0M.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review QuidelOrtho source filings ↗